ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
| 容量 | カタログ番号 | 在庫状況 | 単価 |
|---|---|---|---|
| 500 mg | カートの在庫状況を確認する | ¥75,000 |
この商品について
実験式(ヒル表記法):
C32H56N2O2
CAS番号:
分子量:
500.80
UNSPSC Code:
12352211
PubChem Substance ID:
NACRES:
NA.85
Quality Level
assay
≥98% (TLC)
form
powder or crystals
functional group
ester
storage temp.
−20°C
SMILES string
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4CC(CC[C@]4(C)[C@H]3CC[C@]12C)OC(=O)NCCN(C)C
InChI
1S/C32H56N2O2/c1-22(2)9-8-10-23(3)27-13-14-28-26-12-11-24-21-25(36-30(35)33-19-20-34(6)7)15-17-31(24,4)29(26)16-18-32(27,28)5/h11,22-23,25-29H,8-10,12-21H2,1-7H3,(H,33,35)/t23-,25?,26+,27-,28+,29+,31+,32-/m1/s1
InChI key
HIHOWBSBBDRPDW-MTIZRNOUSA-N
Application
- Role of interleukin-6 in antigen-specific mucosal immunoglobulin A induction by cationic liposomes.: This study investigates the use of cholesteryl N-(2-dimethylaminoethyl)carbamate in cationic liposomes for enhancing mucosal immunoglobulin A production, highlighting its potential in vaccine development (Tada et al., 2021).
- Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice.: This research demonstrates the efficacy of cholesteryl N-(2-dimethylaminoethyl)carbamate in nasal vaccines, providing a promising strategy for respiratory infection prevention (Tada et al., 2018).
Biochem/physiol Actions
Packaging
Bottomless glass bottle. Contents are inside inserted fused cone.
1 of 1
当該品目 | |||
|---|---|---|---|
| functional group ester | functional group ester | functional group - | functional group - |
| assay ≥98% (TLC) | assay ≥98% (TLC) | assay ≥95% | assay ≥98% (TLC) |
| form powder or crystals | form powder | form powder | form powder |
| storage temp. −20°C | storage temp. −20°C | storage temp. −20°C | storage temp. −20°C |
| Quality Level 100 | Quality Level 200 | Quality Level 200 | Quality Level 200 |
hcodes
Hazard Classifications
Aquatic Chronic 4
保管分類
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Malou Henriksen-Lacey et al.
Molecular pharmaceutics, 8(1), 153-161 (2010-12-02)
The immunostimulatory capacities of cationic liposomes are well-documented and are attributed both to inherent immunogenicity of the cationic lipid and more physical capacities such as the formation of antigen depots and antigen delivery. Very few studies have however been conducted
Gene therapy using DC-Chol liposomes.
Goyal, K. and Huang, L.
Journal of liposome research, 5, 49-60 (1995)
Francesco Cardarelli et al.
Molecular pharmaceutics, 9(2), 334-340 (2011-12-27)
Here we investigate the cellular uptake mechanism and final intracellular fate of two cationic liposome formulations characterized by similar physicochemical properties but very different lipid composition and efficiency for intracellular delivery of DNA. The first formulation is made of cationic
グローバルトレードアイテム番号
| カタログ番号 | GTIN |
|---|---|
| 92243-100MG | 04061833073742 |
| 92243-500MG | 04061833073759 |



